Non-AIDS-defining cancer risk

There is 1 paper on non-AIDS-defining cancer risk in aging research: 1 observational study in people.

Disease

1 paper studies it1 more mentions it1 finding

See all 2 papers on non-AIDS-defining cancer risk

“Increased 4-HNE levels were associated with higher NADC risk in females (aHR = 2.79 [95% CI, 1.14-6.80]) but not in males”
Association of baseline plasma oxidative stress biomarkers with incident non-AIDS-defining cancer risk in people with HIV: a case-cohort studyGeroScience2026doi:10.1007/s11357-026-02613-0
  • Humans1

Associations

1

4-hydroxynonenal

upin humans1

1 study
  1. 4-hydroxynonenal is associated with non-AIDS-defining cancer risk in humans (People with HIV receiving antiretroviral therapy; exploratory subgroup analysis) (aHR 2.79, 95% CI 1.14–6.80).

    “Increased 4-HNE levels were associated with higher NADC risk in females (aHR = 2.79 [95% CI, 1.14-6.80]) but not in males”

    HumansPeople with HIV receiving antiretroviral therapy; exploratory subgroup analysisplasmafemales

    Association of baseline plasma oxidative stress biomarkers with incident non-AIDS-defining cancer risk in people with HIV: a case-cohort study

    GeroScience

More on 4-hydroxynonenal

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months